367 related articles for article (PubMed ID: 32607760)
1. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
2. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
3. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
[TBL] [Abstract][Full Text] [Related]
4. Hyperoside prevents doxorubicin-induced cardiotoxicity by inhibiting NOXs/ROS/NLRP3 inflammasome signaling pathway.
Wei S; Ma W; Jiang C; Liu J; Liu J; Zhang B; Li W
Phytother Res; 2023 Sep; 37(9):4196-4209. PubMed ID: 37246409
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
[TBL] [Abstract][Full Text] [Related]
6. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
[TBL] [Abstract][Full Text] [Related]
8. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
11. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
13. ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.
Cao R; Fang D; Wang J; Yu Y; Ye H; Kang P; Li Z; Wang H; Gao Q
J Diabetes Res; 2019; 2019():4857921. PubMed ID: 31871948
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.
Maayah ZH; Takahara S; Dyck JRB
Arch Toxicol; 2021 Jan; 95(1):1-9. PubMed ID: 32852568
[TBL] [Abstract][Full Text] [Related]
15. The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V; De Laurentiis M; Rea D; Barbieri A; Monti MG; Carbone A; Paccone A; Altucci L; Conte M; Canale ML; Botti G; Maurea N
Cardiovasc Diabetol; 2021 Jul; 20(1):150. PubMed ID: 34301253
[TBL] [Abstract][Full Text] [Related]
16. Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation.
Huang PP; Fu J; Liu LH; Wu KF; Liu HX; Qi BM; Liu Y; Qi BL
Int J Mol Med; 2020 Jan; 45(1):186-194. PubMed ID: 31746354
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
18. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
Zheng Q; Ren Y; Reinach PS; She Y; Xiao B; Hua S; Qu J; Chen W
Exp Eye Res; 2014 Aug; 125():1-8. PubMed ID: 24836981
[TBL] [Abstract][Full Text] [Related]
20. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells.
Huang Z; Zhuang X; Xie C; Hu X; Dong X; Guo Y; Li S; Liao X
Cell Physiol Biochem; 2016; 40(6):1578-1590. PubMed ID: 27997926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
